Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (25111)	12/9/1998 8:06:00 PM
From: S.C. Barnard	Read Replies (1) \| Respond to of 119973

QW- I don't think they have your info on the ASTM thread--or do they? No harm sending it there- also Yahoo..

To: QuietWon who wrote (25111)	12/9/1998 8:08:00 PM
From: HandsOn	Respond to of 119973

Good luck, just think CTII might have increased volume and small gap Tomorrow, if no news from ASTM most will be running for the exits Tomorrow.

To: QuietWon who wrote (25111)	12/9/1998 8:21:00 PM
From: brent gephart	Respond to of 119973

RXSD: I know you are all slap happy with ASTM, BUT I think RXSD news is also very good. biz.yahoo.com Especially this part. "ProteoTech, Inc. is a drug discovery company focused on therapeutics and diagnostics for human disease utilizing proteoglycan technologies. The ''amyloid diseases'' all involve the accumulation of specific proteoglycans believed to augment the amyloid process and inhibit the body's natural ability to remove unwanted ''amyloid deposits.'' Proteoglycans are synthesized by virtually all cells of the body and play significant roles in the pathogenesis of a number of human diseases, including Alzheimer's, Down's syndrome, cancer, arthritis, atherosclerosis, heart disease and AIDS. Visit the Company's web site at www.proteotech.com"